On the Cancer Frontier: One Man, One Disease, and a Medical Revolution

Overview


In 1950, a diagnosis of cancer was all but a death sentence. Mortality rates only got worse, and as late as 1986, an article in the New England Journal of Medicine lamented: “We are losing the war against cancer.” Cancer is one of humankind’s oldest and most persistent enemies; it has been called the existential disease.

But we are now entering a new, and more positive, phase in this long campaign. While cancer has not been cured—and a cure may elude us for a long time ...

See more details below
Hardcover
$19.36
BN.com price
(Save 28%)$26.99 List Price

Pick Up In Store

Reserve and pick up in 60 minutes at your local store

Other sellers (Hardcover)
  • All (17) from $1.99   
  • New (10) from $6.03   
  • Used (7) from $1.99   
On the Cancer Frontier: One Man, One Disease, and a Medical Revolution

Available on NOOK devices and apps  
  • NOOK Devices
  • Samsung Galaxy Tab 4 NOOK
  • NOOK HD/HD+ Tablet
  • NOOK
  • NOOK Color
  • NOOK Tablet
  • Tablet/Phone
  • NOOK for Windows 8 Tablet
  • NOOK for iOS
  • NOOK for Android
  • NOOK Kids for iPad
  • PC/Mac
  • NOOK for Windows 8
  • NOOK for PC
  • NOOK for Mac
  • NOOK for Web

Want a NOOK? Explore Now

NOOK Book (eBook)
$14.99
BN.com price
(Save 44%)$26.99 List Price

Overview


In 1950, a diagnosis of cancer was all but a death sentence. Mortality rates only got worse, and as late as 1986, an article in the New England Journal of Medicine lamented: “We are losing the war against cancer.” Cancer is one of humankind’s oldest and most persistent enemies; it has been called the existential disease.

But we are now entering a new, and more positive, phase in this long campaign. While cancer has not been cured—and a cure may elude us for a long time yet—there has been a revolution in our understanding of its nature. Years of brilliant science have revealed how this individualistic disease seizes control of the foundations of life—our genes—and produces guerrilla cells that can attack and elude treatments. Armed with those insights, scientists have been developing more effective weapons and producing better outcomes for patients. Paul A. Marks, MD, has been a leader in these efforts to finally control this devastating disease.

Marks helped establish the strategy for the “war on cancer” in 1971 as a researcher and member of President Nixon’s cancer panel. As the president and chief executive officer for nineteen years at the world’s pre-eminent cancer hospital, the Memorial Sloan-Kettering Cancer Center, he was instrumental in ending the years of futility. He also developed better therapies that promise a new era of cancer containment. Some cancers, like childhood leukemia and non-Hodgkin’s lymphoma, that were once deadly conditions, are now survivable—even curable. New steps in prevention and early diagnosis are giving patients even more hope. On the Cancer Frontier is Marks’ account of the transformation in our understanding of cancer and why there is growing optimism in our ability to stop it.

Read More Show Less

Editorial Reviews

From Barnes & Noble

The media term "war on cancer" evokes images of a war against a standing army, but, as this combination memoir and medical research history amply demonstrates, cancer fighters face numerous ingenious guerilla cells, not one indivisible fighting force. Dr. Paul Marks, the author of this book, has learned that lesson in the trenches: As the longtime president of Memorial Sloan-Kettering Cancer Hospital, he presided over two decades of research and thousands of individual struggles against the tenacity of this disease. Ultimately hopeful, his On the Cancer Frontier takes hard looks at what we have done and what we can do against a malady that was once an almost certain death sentence.

The New York Times Book Review - Danielle Ofri
You can't be against curing cancer, just like you can't be against motherhood or apple pie. But while the notion of finding "the cure" is immensely appealing, it can be misleading, even misguided. Marks…draws from his long career in cancer research to reveal the complex, messy and fascinating reality that regrettably does not fit neatly onto a bumper sticker.
Publishers Weekly
12/23/2013
Blending biography and medical history, Marks, former head of Memorial Sloan-Kettering Cancer Center, and journalist Sterngold, deliver a sobering panorama of cancer research and treatment. "The truth is that basic research has been the engine for most of the successes in the war on cancer," they write, warning that "finding a single ‘cure' for all cancers is unlikely." As a medical student in 1948, Marks was devastated by the loss of a young leukemia patient, but in 1971 the nation declared a "war" on cancer and at Sloan-Kettering, Marks helped lead the charge, backing "novel methods for treating both the disease and the whole patient," introducing a "day hospital" and psychological services. He emphasizes the importance of "serious science" to understand and treat cancer, including the fascinating evolution of a drug that "brought a patient back from the dead" yet was "too weak" to help in most cancers. "I do not think we will ever eliminate the disease so long as cells replicate and we are exposed to the environmental and biological ‘insults' that can cause genetic abnormalities," Marks writes. Nevertheless, this survey illustrates a doctor's determination to fight for scientific and medical victories that will extend life and hope. (Mar.)
From the Publisher

“In this boldly presented argument, written with the assistance of Wall Street Journal senior business writer Sterngold, Marks passionately explains how best to pursue a course of action to control cancer’s tenacity. Cancer is protean, individualistic, complex, elusive and efficient… On a level with Lewis Thomas for its clarity and verve in presenting the science of the cell and the ability of cancer to assume multiple guises.” —Kirkus starred review

“It is the story behind the science that makes this book a compelling read, even for non-boffins, who can rely on good metaphors to decipher the jargon... Dr Marks’s fascinating journey through the world of cancer research.”—The Economist

“This well-written, often dramatic book about the nation’s second-largest killer is a cross between memoir and cancer history book… A good addition to the growing number of engaging titles about this disease.”—Booklist

Kirkus Reviews
★ 2014-01-16
Former Memorial Sloan-Kettering Cancer Center president and CEO Marks delivers a panoramic view of developments in cancer research and treatment over the last 40 years, from both the researchers' and administrators' perspectives. In this boldly presented argument, written with the assistance of Wall Street Journal senior business writer Sterngold (Burning Down the House: How Greed, Deceit, and Bitter Revenge Destroyed E.F. Hutton, 1990), Marks passionately explains how best to pursue a course of action to control cancer's tenacity. Cancer is protean, individualistic, complex, elusive and efficient. "The truth," writes the author, "uncomfortable and inconvenient as it may be, is that medical science has never faced a more inscrutable, more mutable, or more ruthless adversary." Thus, understanding its biology, as well as its ability to shape-shift between patients, is vital, and we must also remember that as long as cell division is how we propagate and survive, cancers will develop, for that, too, is how they work. It's not surprising that Marks calls cancer "the existential illness." This excellent elementary grounding in cancer's workings allows readers to appreciate the importance of, say, the differences between empirical and mechanistic methods of developing treatments; why seemingly random advances in molecular biology and genetics are potentially valuable ("basic research has been the engine for most of the successes in the war on cancer"); why flexibility in research is critical to its creativity and innovation; and why a close coordination between the lab and the clinic, the diagnostic and therapeutic programs, researchers and doctors, is so essential. Marks also interweaves his own story into the changes in cancer medicine: his particular research interests against the background of the politics of medicine and how to "not throw too much money at the false promise of quick cures." Most importantly, we must translate scientific insights into therapies. On a level with Lewis Thomas for its clarity and verve in presenting the science of the cell and the ability of cancer to assume multiple guises.
Read More Show Less

Product Details

  • ISBN-13: 9781610392525
  • Publisher: PublicAffairs
  • Publication date: 3/11/2014
  • Pages: 272
  • Sales rank: 170,339
  • Product dimensions: 5.90 (w) x 8.40 (h) x 1.20 (d)

Meet the Author


Paul Marks, MD, led the Memorial Sloan-Kettering Cancer Center for nineteen years and has been an advisor on national cancer policy. He was awarded the President’s National Medal of Science, and Memorial Sloan-Kettering has established the Paul Marks Prize for Cancer Research to recognize promising young scientists. James Sterngold is a senior special writer for the Wall Street Journal, and previously spent eighteen years as a correspondent at the New York Times.
Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)